Transplantation barriersGiven the extent of the natural polymorphism in a population, the donor and the recipient will always differ for allelic variants of numerous proteins (except for monozygote twins). Such differences will represent transplantation barriers when recognized by the immune system. Alloantigenic structures
Role and recognition of the alloantigenic structures in transplantationsWhich type of alloantigenic structure represents the strongest (+++) transplantation barrier depends on the type of transplantation:
The response to histoincompatible tissues (incompatible MHC and/or mHC) was designated as allorecognition. Histocompatibility antigens can be recognized by (allo)antibodies and by T cells. Allorecognition at the basis of a rejection of an organ have many points in common with the allorecognition causing Graft versus Host Disease. The response is initiated when alloantigens expressed by the stimulator are recognized by so called "alloreactive" T cells of the responder. Read more... Which histocompatibility antigen is recognized and whether the antibody or T cell response prevails depends on the type of transplantation as well as of the degree of matching betweeen stimulator and responder. Read more... XenotransplantantionXenotransplantation involves transplanting living cells, tissues or organs between species, and in particular, from animals to humans. It is being considered because worldwide the demand for human cell, tissue and organ donation far exceeds the supply. The main risk for a person receiving animal transplant therapy is that the transplant might not function properly. However, there is also a risk that one of the wide range of viral, bacterial and other infections known to occur in the source animals will infect the transplant recipient. Read more... |